OraSure Technologies Inc (OSUR) - Multiplikator Forward P/S
The forward P/S trend reflects market expectations for OraSure Technologies (OSUR), with the latest reading standing at 2.10. Valuation growth is driven by partnerships with the public sector and clinics to implement rapid diagnostics. Management is expanding home testing and biomaterial collection methods. Stability is supported by high plant utilization and the planned automation of reagent filling lines, which minimizes technical risks.
Rincian metrik komprehensif lan analitis OraSure Corp (OSUR)
- rega pasar lan target rega analis:
- indikator kapitalisasi pasar:
- statistik nilai buku emiten:
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas OraSure Technologies|OSUR - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal OraSure Technologies|OSUR - Utang kumulatif perusahaan|Utang marang nilai buku OraSure Corp|OSUR - Silihan lan utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan OraSure|Rasio cepet orasure.com
- data bathi bisnis lan rasio investasi:
OSUR - Penghasilan resik perusahaan|Proyeksi bathi mangsa ngarep OraSure Technologies|OSUR - Koefisien rega marang bathi|Pangali Forward P/E OraSure Technologies Inc|OSUR - Koefisien bali modal nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan OraSure Corp|OSUR - Bathi operasional sadurunge amortisasi|Bathi saben saham sajrone rolas wulan pungkasan OraSure|OSUR - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan orasure.com|OSUR - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep OraSure Technologies
- indikator volume dodolan lan pendapatan:
Analisis wiwitan perusahaan:OraSure (OSUR)
OraSure Technologies (OSUR) possesses strong pricing power in the rapid testing segment, allowing the market to bake a high premium into the forward P/S metric. This chart reflects the ratio of current market capitalization to expected annual revenue, enabling investors to quickly assess shifts in market expectations following new guidance and determine the balance between growth potential and the risk of asset overvaluation.
Pesaing wigati
Rasio rega marang prakiraan pendapatan Agilent A|Rega forward marang dodolan DGX|Illumina Corp - Multiplikator Forward P/S|EXAS - Multiplikator Forward P/S|Revvity, Inc. (RVTY) - Rasio rega marang prakiraan pendapatan|BIO - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan NNNN|Multiplikator Forward P/S Sotera Health Corp|Rasio rega marang prakiraan pendapatan QuidelOrtho Corp (QDEL)|OPK (OPKO Health Corp.) - Rega forward marang dodolan|Multiplikator Forward P/S CDNA (CareDx, Inc)|maravai.com (MRVI) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|FLGT: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan LAB (Standard BioTools Inc)|CTKB (Cytek Bio) - Multiplikator forward rega marang pendapatan|XGN: Rasio rega marang pendapatan sing dikarepake|MDXH (MDxHealth SA) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep luciddx.com LUCD|Multiplikator Forward P/S PRE|Multiplikator forward rega marang pendapatan imdxinc.com IMDX|Multiplikator Forward P/S TRIB (Trinity Biotech)|Rega forward marang dodolan PRPH|AIMD - Rasio rega marang prakiraan pendapatan|CODX (codiagnostics.com) - Kapitalisasi marang prakiraan pendapatan|HeartSciences (HSCS) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Biomerica Inc. (BMRA)|Rasio rega marang prakiraan pendapatan Cardio Diagnostics Holdings Inc.|Rasio rega marang prakiraan pendapatan ONCO|Rasio rega marang prakiraan pendapatan Virax Biolabs Group (VRAX)|BJDX - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Multiplikator Forward P/S AWH (Aspira Women's Health Inc.)|Prakiraan rega marang pendapatan Accelerate Diagnostics Inc.|centogene.com - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Enzo Biochem, Inc. ENZ|FRES: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Genetic Technologies Limited (GENE)|Rasio rega marang prakiraan pendapatan 23andMe|Psychemedics Corp. (PMD) - Rasio kapitalisasi marang dodolan sing dikarepake
